DE19632423A1 - Thienopyrimidine - Google Patents

Thienopyrimidine

Info

Publication number
DE19632423A1
DE19632423A1 DE19632423A DE19632423A DE19632423A1 DE 19632423 A1 DE19632423 A1 DE 19632423A1 DE 19632423 A DE19632423 A DE 19632423A DE 19632423 A DE19632423 A DE 19632423A DE 19632423 A1 DE19632423 A1 DE 19632423A1
Authority
DE
Germany
Prior art keywords
pyrimidine
chloro
pyridin
thieno
methylthieno
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19632423A
Other languages
German (de)
English (en)
Inventor
Rochus Dr Jonas
Pierre Prof Dr Schelling
Franz-Werner Dr Kluxen
Maria Christadler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority to DE19632423A priority Critical patent/DE19632423A1/de
Priority to IL12850497A priority patent/IL128504A/xx
Priority to SI9730518T priority patent/SI0920431T1/xx
Priority to CN97197179A priority patent/CN1081638C/zh
Priority to JP50934398A priority patent/JP4405593B2/ja
Priority to US09/230,806 priority patent/US6110920A/en
Priority to RU99104796/04A priority patent/RU2199541C2/ru
Priority to PCT/EP1997/004139 priority patent/WO1998006722A1/de
Priority to ES97940047T priority patent/ES2191192T3/es
Priority to PT97940047T priority patent/PT920431E/pt
Priority to DK97940047T priority patent/DK0920431T3/da
Priority to PL97331538A priority patent/PL190174B1/pl
Priority to HU0001607A priority patent/HUP0001607A3/hu
Priority to DE59709404T priority patent/DE59709404D1/de
Priority to HK00100583.3A priority patent/HK1021731B/xx
Priority to CZ1999448A priority patent/CZ287772B6/cs
Priority to KR10-1999-7001153A priority patent/KR100502271B1/ko
Priority to AU42035/97A priority patent/AU725227B2/en
Priority to UA99031300A priority patent/UA55421C2/uk
Priority to BR9711062A priority patent/BR9711062A/pt
Priority to TR1999/00308T priority patent/TR199900308T2/xx
Priority to AT97940047T priority patent/ATE233265T1/de
Priority to CA002263561A priority patent/CA2263561C/en
Priority to SK164-99A priority patent/SK282823B6/sk
Priority to NZ334600A priority patent/NZ334600A/xx
Priority to EP97940047A priority patent/EP0920431B1/de
Priority to ZA9707156A priority patent/ZA977156B/xx
Priority to TW086111481A priority patent/TW359672B/zh
Priority to ARP970103649A priority patent/AR009052A1/es
Publication of DE19632423A1 publication Critical patent/DE19632423A1/de
Priority to NO990643A priority patent/NO990643L/no
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19632423A 1996-08-12 1996-08-12 Thienopyrimidine Withdrawn DE19632423A1 (de)

Priority Applications (30)

Application Number Priority Date Filing Date Title
DE19632423A DE19632423A1 (de) 1996-08-12 1996-08-12 Thienopyrimidine
KR10-1999-7001153A KR100502271B1 (ko) 1996-08-12 1997-07-30 티에노피리미딘
CZ1999448A CZ287772B6 (en) 1996-08-12 1997-07-30 Thienopyrimidine derivative, process of its preparation and pharmaceutical preparation in which it is comprised
CN97197179A CN1081638C (zh) 1996-08-12 1997-07-30 噻吩并嘧啶化合物
JP50934398A JP4405593B2 (ja) 1996-08-12 1997-07-30 チエノピリミジン類
US09/230,806 US6110920A (en) 1996-08-12 1997-07-30 Thienopyrimidines
RU99104796/04A RU2199541C2 (ru) 1996-08-12 1997-07-30 Тиенопиримидины, способ их получения (варианты), фармацевтическая композиция и способ ее получения
PCT/EP1997/004139 WO1998006722A1 (de) 1996-08-12 1997-07-30 Thienopyrimidine
ES97940047T ES2191192T3 (es) 1996-08-12 1997-07-30 Tienopirimidinas.
PT97940047T PT920431E (pt) 1996-08-12 1997-07-30 Tienopirimidinas
DK97940047T DK0920431T3 (da) 1996-08-12 1997-07-30 Thienopyrimidiner.
PL97331538A PL190174B1 (pl) 1996-08-12 1997-07-30 Nowe związki, tienopirymidyny, sposób ich wytwarzania oraz preparat farmaceutyczny
HU0001607A HUP0001607A3 (en) 1996-08-12 1997-07-30 Thienopyrimidine derivatives, pharmaceutical compositions containing them, process for their preparation and use of the compounds
DE59709404T DE59709404D1 (en) 1996-08-12 1997-07-30 Thienopyrimidine
HK00100583.3A HK1021731B (en) 1996-08-12 1997-07-30 Thienopyrimidines
IL12850497A IL128504A (en) 1996-08-12 1997-07-30 2-HETEROARYL-N-PHENYL (ALKYL) THIENO [2,3-d] PYRIMIDIN-4-AMINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BR9711062A BR9711062A (pt) 1996-08-12 1997-07-30 Tienopirimidinas
SI9730518T SI0920431T1 (en) 1996-08-12 1997-07-30 Thienopyrimidines
UA99031300A UA55421C2 (uk) 1996-08-12 1997-07-30 Тієнопіримідини, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб її одержання
AU42035/97A AU725227B2 (en) 1996-08-12 1997-07-30 Thienopyrimidines
TR1999/00308T TR199900308T2 (xx) 1996-08-12 1997-07-30 Tiyenopirimidinler
AT97940047T ATE233265T1 (de) 1996-08-12 1997-07-30 Thienopyrimidine
CA002263561A CA2263561C (en) 1996-08-12 1997-07-30 Thienopyrimidines
SK164-99A SK282823B6 (sk) 1996-08-12 1997-07-30 Derivát tienopyrimidínu, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje
NZ334600A NZ334600A (en) 1996-08-12 1997-07-30 Thienopyrimidines inhibiting phosphodiesterase V for treating cardiovascular disease and impotency
EP97940047A EP0920431B1 (de) 1996-08-12 1997-07-30 Thienopyrimidine
ZA9707156A ZA977156B (en) 1996-08-12 1997-08-11 Thienopyrimidines.
TW086111481A TW359672B (en) 1996-08-12 1997-08-11 Thienopyrimidines ad phosphodiesterase V antagonists, process for the production thereof and pharmaceutical compositions containing the same
ARP970103649A AR009052A1 (es) 1996-08-12 1997-08-12 Tienopirimidinas, un procedimiento para su preparacion, empleo de las mismas para preparar un medicamento, preparaciones farmaceuticas que lascontienen y un procedimiento para obtener estas preparaciones farmaceuticas
NO990643A NO990643L (no) 1996-08-12 1999-02-11 Tienopyrimidiner

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19632423A DE19632423A1 (de) 1996-08-12 1996-08-12 Thienopyrimidine

Publications (1)

Publication Number Publication Date
DE19632423A1 true DE19632423A1 (de) 1998-02-19

Family

ID=7802392

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19632423A Withdrawn DE19632423A1 (de) 1996-08-12 1996-08-12 Thienopyrimidine
DE59709404T Expired - Lifetime DE59709404D1 (en) 1996-08-12 1997-07-30 Thienopyrimidine

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE59709404T Expired - Lifetime DE59709404D1 (en) 1996-08-12 1997-07-30 Thienopyrimidine

Country Status (28)

Country Link
US (1) US6110920A (enExample)
EP (1) EP0920431B1 (enExample)
JP (1) JP4405593B2 (enExample)
KR (1) KR100502271B1 (enExample)
CN (1) CN1081638C (enExample)
AR (1) AR009052A1 (enExample)
AT (1) ATE233265T1 (enExample)
AU (1) AU725227B2 (enExample)
BR (1) BR9711062A (enExample)
CA (1) CA2263561C (enExample)
CZ (1) CZ287772B6 (enExample)
DE (2) DE19632423A1 (enExample)
DK (1) DK0920431T3 (enExample)
ES (1) ES2191192T3 (enExample)
HU (1) HUP0001607A3 (enExample)
IL (1) IL128504A (enExample)
NO (1) NO990643L (enExample)
NZ (1) NZ334600A (enExample)
PL (1) PL190174B1 (enExample)
PT (1) PT920431E (enExample)
RU (1) RU2199541C2 (enExample)
SI (1) SI0920431T1 (enExample)
SK (1) SK282823B6 (enExample)
TR (1) TR199900308T2 (enExample)
TW (1) TW359672B (enExample)
UA (1) UA55421C2 (enExample)
WO (1) WO1998006722A1 (enExample)
ZA (1) ZA977156B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2261863C2 (ru) * 2000-06-29 2005-10-10 Мерк Патент Гмбх 2-аминоалкилтиено[2,3-d]пиримидины, способ их получения, лекарственный препарат и способ его получения

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19819023A1 (de) * 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6331571B1 (en) 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
US6339106B1 (en) 1999-08-11 2002-01-15 Sepracor, Inc. Methods and compositions for the treatment and prevention of sexual dysfunction
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
KR20010105399A (ko) 1999-03-30 2001-11-28 쓰끼하시 다미까따 티에노피리미딘 화합물 및 그의 염, 및 그들의 제조 방법
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
DE19950647A1 (de) * 1999-10-21 2001-04-26 Merck Patent Gmbh Imidazolderivate als Phosphodiesterase VII-Hemmer
KR20030034232A (ko) * 2000-09-29 2003-05-01 닛뽕소다 가부시키가이샤 티에노피리미딘 화합물 및 그 염 및 제조방법
BR0206853A (pt) * 2001-02-02 2004-01-13 Merck Patent Ges Mit Beschroen Formulação farmacêutica compreendendo pirazolo[4,3-d]pirimidinas e antagonistas de receptor de endotelina ou tienopirimidinas e antagonistas de receptor de endotelina
US6610887B2 (en) 2001-04-13 2003-08-26 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
CN101100472A (zh) * 2001-04-30 2008-01-09 美国拜尔公司 4-氨基-5,6-取代的噻吩并[2,3-d]嘧啶化合物及其应用
ES2252540T3 (es) * 2001-09-04 2006-05-16 Akzo Nobel N.V. Tieno (2,3-d) pirimidinas glicino-sustituidas con actividad agonistas combinada lh y fsh.
WO2003035653A1 (en) * 2001-10-26 2003-05-01 Nippon Soda Co.,Ltd. Pyridothienopyrimidine compound and salt thereof
US7153412B2 (en) 2001-12-28 2006-12-26 Kabushiki Kaisha Toyota Chuo Kenkyusho Electrodes, electrochemical elements, gas sensors, and gas measurement methods
US6962940B2 (en) 2002-03-20 2005-11-08 Celgene Corporation (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
US7276529B2 (en) 2002-03-20 2007-10-02 Celgene Corporation Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
US7208516B2 (en) 2002-03-20 2007-04-24 Celgene Corporation Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
US7893101B2 (en) 2002-03-20 2011-02-22 Celgene Corporation Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
AR044743A1 (es) * 2002-09-26 2005-10-05 Nihon Nohyaku Co Ltd Herbicida, metodo de emplearlo, derivados de tienopirimidina sustituida,compuestos intermediarios, y procedimientos que se utilizan para producirlos,
GB0320300D0 (en) * 2003-08-29 2003-10-01 Cancer Rec Tech Ltd Pyrimidothiophene compounds
DE10351436A1 (de) * 2003-11-04 2005-06-09 Merck Patent Gmbh Verwendung von Thienopyrimidinen
GB0420722D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
GB0420719D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
AR059898A1 (es) * 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200900065A (en) * 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) * 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
US9603848B2 (en) 2007-06-08 2017-03-28 Senomyx, Inc. Modulation of chemosensory receptors and ligands associated therewith
DK2203439T3 (da) * 2007-09-14 2011-04-18 Ortho Mcneil Janssen Pharm 1',3'-disubstituerede 4-phenyl-3,4,5,6-tetrahydro-2H,1'H-[1,4']-bipyridinyl-2'-oner
KR20100080597A (ko) * 2007-09-14 2010-07-09 오르토-맥닐-얀센 파마슈티칼스 인코포레이티드 1,3-이치환된-4-페닐-1h-피리딘-2-온
BRPI0817101A2 (pt) 2007-09-14 2017-05-09 Addex Pharmaceuticals Sa 4-(aril-x-fenil)-1h-piridin-2-onas 1,3-dissubstituídas
MX2010005110A (es) * 2007-11-14 2010-09-09 Ortho Mcneil Janssen Pharm Derivados de imidazo[1,2-a]piridina y su uso como moduladores alostericos positivos de los receptores de glutamato metabotropico 2.
US20100227853A1 (en) * 2008-04-18 2010-09-09 Trustees Of Boston College Inhibitors of cyclic amp phosphodiesterases
DK2323997T3 (en) 2008-07-31 2017-12-11 Senomyx Inc METHODS AND INTERMEDIATES FOR THE MANUFACTURE OF SWEET TASTE AMPLIFIERS
AU2009289784B2 (en) 2008-09-02 2012-03-22 Addex Pharma S.A. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
US8697689B2 (en) 2008-10-16 2014-04-15 Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
RU2512283C2 (ru) 2008-11-28 2014-04-10 Янссен Фармасьютикалз, Инк. Производные индола и бензоксазина в качестве модуляторов метаботропных глутаматных рецепторов
JO2907B1 (en) 2009-05-12 2015-09-15 اديكس فرما اس ايه Pyridine derivatives 1, 2, 4 trisolo [4, 3-A] and their uses as positive LLs for 2MGLUR receptors
NZ596053A (en) 2009-05-12 2013-05-31 Janssen Pharmaceuticals Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
EP2661435B1 (en) 2010-11-08 2015-08-19 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
ES2536433T3 (es) 2010-11-08 2015-05-25 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
CN103298810B (zh) 2010-11-08 2016-03-16 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
HK1198475A1 (en) 2011-07-19 2015-05-08 无限药品股份有限公司 Heterocyclic compounds and uses thereof
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
ES2806606T3 (es) 2012-08-06 2021-02-18 Firmenich Incorporated Modificador del sabor dulce
JO3155B1 (ar) 2013-02-19 2017-09-20 Senomyx Inc معدِّل نكهة حلوة
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
EA033889B1 (ru) 2014-01-21 2019-12-05 Янссен Фармацевтика Нв Комбинация на основе лиганда sv2a и положительного аллостерического модулятора метаботропного глутаматергического рецептора 2 подтипа
HUE045610T2 (hu) 2014-01-21 2020-01-28 Janssen Pharmaceutica Nv 2-es altípusú metabotróp glutamáterg receptor pozitív allosztérikus modulátorait vagy ortosztérikus agonistáit tartalmazó kombinációk és alkalmazásuk
MX2016014384A (es) 2014-06-23 2017-01-20 Celgene Corp Apremilast para el tratamiento de una enfermedad del higado o una anormalidad en la funcion del higado.
WO2017112777A1 (en) 2015-12-22 2017-06-29 SHY Therapeutics LLC Compounds for the treatment of cancer and inflammatory disease
BR112019027640A2 (pt) 2017-06-21 2020-07-07 SHY Therapeutics LLC composto, método para testar a capacidade de um ou mais compostos, método para inibir a função de ras, método para inibir a função de rho, método para inibir a função de rac, composição farmacêutica
CN112703193A (zh) 2018-08-07 2021-04-23 弗门尼舍公司 5-取代的4-氨基-1H-苯并[c][1,2,6]噻二嗪2,2-二氧化物及其制剂和用途
WO2020132071A1 (en) 2018-12-19 2020-06-25 Shy Therapeutics. Llc Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and f1brotic disease
CN116178374B (zh) * 2023-01-13 2024-10-08 河北医科大学 小电导钙激活钾离子通道激动剂及其合成和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1570494A (en) * 1975-11-28 1980-07-02 Ici Ltd Thienopyrimidine derivatives and their use as pesticides
ZA782648B (en) * 1977-05-23 1979-06-27 Ici Australia Ltd The prevention,control or eradication of infestations of ixodid ticks
JP2657760B2 (ja) * 1992-07-15 1997-09-24 小野薬品工業株式会社 4−アミノキナゾリン誘導体およびそれを含有する医薬品
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2261863C2 (ru) * 2000-06-29 2005-10-10 Мерк Патент Гмбх 2-аминоалкилтиено[2,3-d]пиримидины, способ их получения, лекарственный препарат и способ его получения

Also Published As

Publication number Publication date
EP0920431A1 (de) 1999-06-09
NO990643D0 (no) 1999-02-11
DK0920431T3 (da) 2003-06-02
UA55421C2 (uk) 2003-04-15
DE59709404D1 (en) 2003-04-03
AU4203597A (en) 1998-03-06
JP2000516223A (ja) 2000-12-05
BR9711062A (pt) 1999-08-17
SK16499A3 (en) 1999-06-11
CN1227560A (zh) 1999-09-01
AR009052A1 (es) 2000-03-08
CZ44899A3 (cs) 1999-05-12
IL128504A (en) 2003-01-12
CA2263561A1 (en) 1998-02-19
AU725227B2 (en) 2000-10-12
TW359672B (en) 1999-06-01
ATE233265T1 (de) 2003-03-15
CZ287772B6 (en) 2001-01-17
NZ334600A (en) 2000-07-28
TR199900308T2 (xx) 1999-04-21
SK282823B6 (sk) 2002-12-03
PT920431E (pt) 2003-07-31
US6110920A (en) 2000-08-29
ZA977156B (en) 1998-02-19
NO990643L (no) 1999-02-11
KR100502271B1 (ko) 2005-07-22
HK1021731A1 (en) 2000-06-30
PL331538A1 (en) 1999-07-19
CA2263561C (en) 2007-02-20
KR20000029932A (ko) 2000-05-25
CN1081638C (zh) 2002-03-27
HUP0001607A3 (en) 2002-09-30
RU2199541C2 (ru) 2003-02-27
IL128504A0 (en) 2000-01-31
WO1998006722A1 (de) 1998-02-19
EP0920431B1 (de) 2003-02-26
PL190174B1 (pl) 2005-11-30
HUP0001607A2 (hu) 2000-10-28
ES2191192T3 (es) 2003-09-01
JP4405593B2 (ja) 2010-01-27
SI0920431T1 (en) 2003-08-31

Similar Documents

Publication Publication Date Title
DE19632423A1 (de) Thienopyrimidine
WO1998017668A1 (de) Thienopyrimidine mit pde v inhibierender wirkung
EP1036078B1 (de) Thienopyrimidine
EP1337256A2 (de) Verwendung von thienopyrimidinen
EP1210349B1 (de) Pyrazolo[4, 3-d]pyrimidine
EP1084125B1 (de) Kondensierte thienopyrimidine mit pde v inhibierender wirkung
DE19928146A1 (de) Thienopyrimidine
DE10064994A1 (de) Sulfamidothienopyrimidine
EP1355649A2 (de) Pharmazeutische formulierung enthaltend pyrazolo 4,3-d]pyrimidine und nitrate oder thienopyrimidine und nitrate
DE10058662A1 (de) Verwendung von Pyrazolo[4,3-d]pyrimidinen
EP1294729B1 (de) 2-aminoalkyl-thieno[2,3-d]pyrimidine
EP1351962B1 (de) Thienopyrimidine
DE19944604A1 (de) Aminderivate
DE19943815A1 (de) Verwendung von Thienopyrimidinen
MXPA99001387A (en) Thienopyrimidines
DE10104096A1 (de) Pharmazeutische Formulierung enthaltend Thienopyrimidine und Nitrate
DE10104801A1 (de) Pharmazeutische Formulierungen enthaltend Thienopirimidine und Endothelin-Rezeptor-Antagonisten (2)

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee